-
Xu Jinghe meets with Acting Director of Indonesia’s BPOM
2024-07-04
On June 27, Xu Jinghe, Deputy Commissioner of China's National Medical Products Administration (NMPA), met with a delegation led by Rizka Andalucia, Acting Director of Indonesia's food and drug authority BPOM, also the Director-general of Pharmaceutical and Medical Devices of the Indonesian Ministry of Health.
-
China's quantity and quality of innovative drugs joins global lead
2024-06-19
Huang Guo, deputy director of the National Medical Products Administration, said that from January to May of this year, a total of 20 innovative medicines and 21 innovative medical equipment have gained market approval on the mainland.
-
NMPA holds meetings on vaccine regulatory QMS
2024-06-19
The National Medical Products Administration (NMPA) held meetings on the construction of the vaccine regulatory quality management system (QMS) in Nanjing, Jiangsu province, and Urumqi, Xinjiang Uygur autonomous region, on May 16 and May 30, respectively, in a bid to enhance the construction of the QMS and facilitate the cohesion and coordination of the QMS in the vaccine regulatory system.
-
NMPA holds meeting to review vaccine regulatory QMS
2024-05-28
The National Medical Products Administration (NMPA) held a meeting on May 11 to carry out the 2023 annual review of the vaccine regulatory quality management system (QMS).
-
China makes headway in enhancing grassroots medical services
2024-05-08
China has worked to bolster its public health care services at various levels, aiming to improve its people's well-being, a senior National Health Commission (NHC) official said on Tuesday.
-
China moves to improve critical care medical services
2024-05-07
China's National Health Commission and other authorities on Monday issued a set of guidelines to improve the country's critical care medical services capacity.
